He said an antipsychotic drug caused him to grow breasts. Now, Johnson & Johnson owes him $8 billion, jury rules.
On Tuesday, a Philadelphia jury ruled that the company and its subsidiary, Janssen Pharmaceuticals, owe $8 billion in punitive damages to Murray, who is now 26. That whopping sum of money, which at least one legal expert says is likely to be reduced, is among thousands of similar cases against Johnson & Johnson regarding the drug. The ruling marks another costly setback for Johnson & Johnson. ADLast week, however, Johnson & Johnson reached a $20.4 million settlement with two Ohio counties in another massive suit on the opioid crisis. According to the companyâs most recent SEC filings in June, 13,400 people are suing Johnson & Johnson over Risperdal.